At Manningham Medical Centre, you can find all the data about Sirux Medical Study. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


    https://clinicaltrials.gov/ct2/show/NCT01985126
    For all study drug administrations, participants will receive pre- and post-infusion medications for the prevention of infusion related reactions. Follow-up will …

    https://clinicaltrials.gov/ct2/show/NCT05126277
    This trial will evaluate the efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or ianalumab given every 12 weeks (q12w) …

Daratumumab monotherapy in patients with heavily …

    https://pubmed.ncbi.nlm.nih.gov/32470437/
    Background: Daratumumab showed encouraging efficacy as monotherapy in patients with heavily pretreated multiple myeloma in the GEN501 and SIRIUS studies. Here we report …

Daratumumab monotherapy in patients with treatment …

    https://pubmed.ncbi.nlm.nih.gov/26778538/
    Background: New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs. We …



Need more information about Sirux Medical Study?

At Manningham Medical Centre, we collected data on more than just Sirux Medical Study. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.